Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 24Breast Neoplasms 11Prostatic Neoplasms 10Colorectal Neoplasms 10Hematologic Neoplasms 7Ovarian Neoplasms 6Lung Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Advanced Cancer 4Uterine Cervical Neoplasms 3Rectal Neoplasms 3Lymphoma 3Head and Neck Neoplasms 3Gastrointestinal Neoplasms 3Sarcoma 2Peritoneal Neoplasms 2Pain 2Neoplasm Metastasis 2Mouth Neoplasms 2Melanoma 2Low Anterior Resection Syndrome 2Hematopoietic and Lymphoid System Neoplasm 2Fatigue 2Endometrial Neoplasms 2Depression 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Colonic Neoplasms 2Brain Neoplasms 2Bone Neoplasms 2

Interventions

Brentuximab Vedotin 17fludarabine 9Cyclophosphamide 9dacetuzumab 6Lenalidomide 6Bortezomib 6ruxolitinib 5fludarabine phosphate 5Rituximab 5Melphalan 5Dexamethasone 4Busulfan 4lintuzumab 3Whole-Body Irradiation 3Mycophenolic Acid 3Imatinib Mesylate 3Granulocyte Colony-Stimulating Factor 3Doxorubicin 3Calcium Dobesilate 3Azacitidine 3vosaroxin 2spartalizumab 2ponatinib 2nilotinib 2Vincristine 2Thiotepa 2Tacrolimus 2Sugars 2Stem Cell Transplantation 2Rifampin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hematologic Diseases × Interviews as Topic × Clear all
NCT00909207 2014-07-14

Patient-Reported Outcomes Version of Common Terminology Criteria (CTCPRO) Cognitive Debriefing

M.D. Anderson Cancer Center

Completed
20 enrolled

Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡